Form 4: AbbVie Executive Jeffrey R. Stewart Reports Stock Transaction
SEC Filing
EVP, Chief Commercial Officer of AbbVie, Jeffrey R. Stewart, reports disposition of shares to cover tax obligations.
Summary
- On February 28, 2024, Jeffrey R. Stewart, EVP, Chief Commercial Officer of AbbVie Inc., reported a transaction involving AbbVie's common stock.
- Stewart disposed of 26,121 shares at a price of $178.99 per share to cover tax obligations.
- Following the transaction, Stewart directly owns 93,780 shares of AbbVie common stock.
- Stewart also indirectly owns 1,338 shares through a spousal trust.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock transaction by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of stock transaction |
| 03/01/2024 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.